NASDAQ:CODX - Co-Diagnostics Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $18.00
  • Forecasted Upside: 122.22 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$8.10
▲ +0.04 (0.50%)
1 month | 3 months | 12 months
Get New Co-Diagnostics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CODX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CODX

Average Price Target: $18.00
▲ +122.22% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Co-Diagnostics in the last 3 months. The average price target is $18.00, with a high forecast of $20.00 and a low forecast of $16.00. The average price target represents a 122.22% upside from the last price of $8.10.

Buy

The current consensus among 2 investment analysts is to buy stock in Co-Diagnostics. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/27/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/26/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/24/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/22/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/21/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/21/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/20/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/29/2021Maxim GroupDowngradeBuy ➝ HoldHigh
3/26/2021HC WainwrightLower Price TargetBuy$30.00 ➝ $16.00High
12/15/2020HC WainwrightBoost Price TargetBuy$29.00 ➝ $30.00Medium
11/17/2020Maxim GroupLower Price TargetPositive ➝ Buy$30.00 ➝ $20.00Low
11/17/2020HC WainwrightLower Price TargetBuy$33.00 ➝ $29.00High
8/31/2020HC WainwrightReiterated RatingBuy$33.00Medium
8/14/2020Maxim GroupInitiated CoverageBuy$30.00High
8/14/2020HC WainwrightLower Price TargetBuy$35.00 ➝ $33.00High
8/3/2020HC WainwrightReiterated RatingBuy$35.00High
7/13/2020HC WainwrightReiterated RatingBuy$35.00High
5/27/2020Maxim GroupReiterated RatingBuy$30.00High
5/20/2020Maxim GroupUpgradeHold ➝ BuyLow
4/17/2020HC WainwrightReiterated RatingBuyHigh
3/23/2020HC WainwrightReiterated RatingBuyHigh
3/20/2020Maxim GroupReiterated RatingHoldHigh
3/3/2020Maxim GroupDowngradeBuy ➝ HoldHigh
2/24/2020HC WainwrightBoost Price TargetBuy$2.00 ➝ $4.00High
1/3/2020HC WainwrightReiterated RatingBuy$2.00Low
12/6/2019HC WainwrightReiterated RatingBuy$2.00Low
11/15/2019HC WainwrightReiterated RatingBuy$2.00Low
10/11/2019HC WainwrightReiterated RatingBuy$2.00Low
9/5/2019Maxim GroupSet Price TargetBuy$2.00Low
8/16/2019HC WainwrightReiterated RatingBuy$2.00Low
7/19/2019HC WainwrightSet Price TargetBuy$2.00Medium
7/12/2019HC WainwrightSet Price TargetBuy$2.00Low
7/11/2019Maxim GroupSet Price TargetBuy$2.00Low
6/26/2019HC WainwrightSet Price TargetBuy$2.00High
5/23/2019HC WainwrightSet Price TargetBuy$2.00High
5/17/2019Maxim GroupReiterated RatingBuy$2.00Low
5/16/2019HC WainwrightReiterated RatingBuy$2.00Low
4/17/2019HC WainwrightSet Price TargetBuy$2.00Medium
4/9/2019Maxim GroupInitiated CoverageBuy$2.00Low
3/11/2019HC WainwrightInitiated CoverageBuy$2.00Low
(Data available from 6/20/2016 forward)
Co-Diagnostics logo
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and liquid biopsy test for cancer screening. The company also provides tests that identify genetic traits in plant and animal genomes. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
Read More

Today's Range

Now: $8.10
Low: $7.97
High: $8.48

50 Day Range

MA: $8.47
Low: $7.16
High: $9.54

52 Week Range

Now: $8.10
Low: $7.01
High: $30.99

Volume

1,496,763 shs

Average Volume

1,249,681 shs

Market Capitalization

$232.20 million

P/E Ratio

4.91

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Co-Diagnostics?

The following Wall Street analysts have issued reports on Co-Diagnostics in the last year: HC Wainwright, Maxim Group, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for CODX.

What is the current price target for Co-Diagnostics?

2 Wall Street analysts have set twelve-month price targets for Co-Diagnostics in the last year. Their average twelve-month price target is $18.00, suggesting a possible upside of 122.2%. Maxim Group has the highest price target set, predicting CODX will reach $20.00 in the next twelve months. HC Wainwright has the lowest price target set, forecasting a price of $16.00 for Co-Diagnostics in the next year.
View the latest price targets for CODX.

What is the current consensus analyst rating for Co-Diagnostics?

Co-Diagnostics currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CODX will outperform the market and that investors should add to their positions of Co-Diagnostics.
View the latest ratings for CODX.

What other companies compete with Co-Diagnostics?

How do I contact Co-Diagnostics' investor relations team?

Co-Diagnostics' physical mailing address is 2401 SOUTH FOOTHILL DRIVE SUITE D, SALT LAKE CITY UT, 84124. The company's listed phone number is 801-438-1036 and its investor relations email address is [email protected] The official website for Co-Diagnostics is www.codiagnostics.com.